Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins

被引:16
作者
Damoiseaux, J [1 ]
Jeyasekharan, AD [1 ]
Theunissen, R [1 ]
Tervaert, JWC [1 ]
机构
[1] Univ Hosp Maastricht, Dept Clin & Expt Immunol, NL-6202 AZ Maastricht, Netherlands
来源
AUTOIMMUNITY: CONCEPTS AND DIAGNOSIS AT THE CUTTING EDGE | 2005年 / 1050卷
关键词
antiphospholipid syndrome; autoantibodies; atherosclerosis;
D O I
10.1196/annals.1313.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anticardiolipin antibodies (aCLAs) and antibodies to oxidized-low density lipoproteins (oxLDL) are associated with two distinct diseases: the antiphospholipid syndrome and atherosclerosis. Because both diseases may be apparent in patients with systemic lupus erytbematosus (SLE), it is important to establish the relationship between these two types of antibodies. In the present study, we examined whether sera containing IgM and/or IgG aCLAs also react with LDL that has been oxidized by conjugation with malondialdelayde (MDA-LDL) or by incubation with copper ions (Cu-LDL). Results revealed a clear correlation between IgM aCLAs and IgM anti-MDA-LDL antibodies, and a weak correlation between IgG aCLAs and IgG anti-Cu-LDL antibodies. Cross-reactivity between both antibodies seemed to be limited. Because aCLAs are heterogeneous, only a minor subset of these antibodies may cross-react with oxLDL. Therefore, identification of both antibodies may be relevant for determination of the prognosis of accelerated atherosclerosis in SLE patients.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 24 条
[1]   SERUM ANTIBODIES TO OXIDIZED LOW-DENSITY-LIPOPROTEIN IN PREECLAMPSIA AND CORONARY HEART-DISEASE [J].
ARMSTRONG, VW ;
WIELAND, E ;
DIEDRICH, F ;
RENNER, A ;
RATH, W ;
KREUZER, H ;
KUHN, W ;
OELLERICH, M .
LANCET, 1994, 343 (8912) :1570-1570
[2]   Premature coronary-artery atherosclerosis in systemic lupus erythematosus [J].
Asanuma, Y ;
Oeser, A ;
Shintani, AK ;
Turner, E ;
Olsen, N ;
Fazio, S ;
Linton, MF ;
Raggi, P ;
Stein, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (25) :2407-2415
[3]   PATIENTS WITH EARLY-ONSET PERIPHERAL VASCULAR-DISEASE HAVE INCREASED LEVELS OF AUTOANTIBODIES AGAINST OXIDIZED LDL [J].
BERGMARK, C ;
WU, R ;
DEFAIRE, U ;
LEFVERT, AK ;
SWEDENBORG, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (04) :441-445
[4]   ANTICARDIOLIPIN ANTIBODIES (ACA) DIRECTED NOT TO CARDIOLIPIN BUT TO A PLASMA-PROTEIN COFACTOR [J].
GALLI, M ;
COMFURIUS, P ;
MAASSEN, C ;
HEMKER, HC ;
DEBAETS, MH ;
VANBREDAVRIESMAN, PJC ;
BARBUI, T ;
ZWAAL, RFA ;
BEVERS, EM .
LANCET, 1990, 335 (8705) :1544-1547
[5]   How do antiphospholipid antibodies bind β2-glycoprotein I? [J].
Giles, IP ;
Isenberg, DA ;
Latchman, DS ;
Rahman, A .
ARTHRITIS AND RHEUMATISM, 2003, 48 (08) :2111-2121
[6]   The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta(2) glycoprotein 1 (and other proteins) [J].
Horkko, S ;
Miller, E ;
Branch, DW ;
Palinski, W ;
Witztum, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) :10356-10361
[7]  
Hörkkö S, 2001, CIRCULATION, V103, P941
[8]   THE ANTIPHOSPHOLIPID SYNDROME - 10 YEARS ON [J].
HUGHES, GRV .
LANCET, 1993, 342 (8867) :341-344
[9]  
Kobayashi K, 2001, J LIPID RES, V42, P697
[10]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265